Akanda Corp. (AKAN)
USD 1.13
(0.71%)
USD 1.13
(0.71%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -10.05 Million USD | 50.88% |
| 2022 | -20.17 Million USD | -195.25% |
| 2021 | -6.83 Million USD | -310.23% |
| 2020 | -1.66 Million USD | -84.84% |
| 2019 | -901.23 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.35 Million USD | 0.0% |
| 2023 Q2 | -5.92 Million USD | -103.72% |
| 2023 Q3 | -1.99 Million USD | 66.44% |
| 2023 FY | -9.91 Million USD | 50.88% |
| 2023 Q1 | -2.91 Million USD | 72.12% |
| 2023 Q4 | -2.11 Million USD | -6.28% |
| 2022 Q1 | -5.33 Million USD | -102.11% |
| 2022 FY | -20.17 Million USD | -195.25% |
| 2022 Q3 | -4.75 Million USD | 56.59% |
| 2022 Q4 | -10.44 Million USD | -119.63% |
| 2022 Q2 | -10.95 Million USD | -105.31% |
| 2021 Q3 | -4.04 Million USD | -5465.65% |
| 2021 FY | -6.83 Million USD | -310.23% |
| 2021 Q4 | -2.63 Million USD | 34.82% |
| 2021 Q2 | -72.75 Thousand USD | 0.0% |
| 2021 Q1 | -72.75 Thousand USD | 87.83% |
| 2020 Q4 | -597.99 Thousand USD | 0.0% |
| 2020 FY | -1.66 Million USD | -84.84% |
| 2019 FY | -901.23 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 106.02% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -299.622% |
| Embecta Corp. | 221.5 Million USD | 104.538% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 111.464% |
| PainReform Ltd. | -9.58 Million USD | -4.877% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -110.047% |
| SCYNEXIS, Inc. | 72.66 Million USD | 113.832% |
| Journey Medical Corporation | -2.07 Million USD | -384.871% |
| Safety Shot Inc | -12.18 Million USD | 17.505% |
| Alpha Teknova, Inc. | -35.56 Million USD | 71.736% |
| Bright Green Corporation | -8.89 Million USD | -13.046% |
| Procaps Group, S.A. | 38.97 Million USD | 125.791% |
| Alvotech | -354.86 Million USD | 97.168% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 121.399% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 33.443% |
| Cosmos Health Inc. | -21.83 Million USD | 53.959% |
| Dynavax Technologies Corporation | -37.02 Million USD | 72.855% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | 93.539% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 93.693% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -110.047% |
| Theratechnologies Inc. | -10.62 Million USD | 5.417% |
| Harrow Health, Inc. | 580 Thousand USD | 1832.995% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -113.814% |
| Biofrontera Inc. | -22.67 Million USD | 55.676% |
| DURECT Corporation | -36.88 Million USD | 72.749% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -90.764% |
| Cronos Group Inc. | -81.37 Million USD | 87.648% |
| OptiNose, Inc. | -22.74 Million USD | 55.814% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 104.808% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 74.328% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 179.571% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 180.25% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -131.795% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -61.837% |
| Radius Health, Inc. | -3.92 Million USD | -156.086% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -185.002% |
| ProPhase Labs, Inc. | -21.61 Million USD | 53.494% |
| Phibro Animal Health Corporation | 53.31 Million USD | 118.853% |
| Procaps Group S.A. | 52.32 Million USD | 119.21% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -17.932% |
| Viatris Inc. | 766.2 Million USD | 101.312% |
| Rockwell Medical, Inc. | -6.67 Million USD | -50.695% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -91.309% |
| SIGA Technologies, Inc. | 83.62 Million USD | 112.02% |
| Tilray Brands, Inc. | -174.74 Million USD | 94.248% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 207.72% |
| Shineco, Inc. | -17.06 Million USD | 41.102% |
| PetIQ, Inc. | 60.01 Million USD | 116.748% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -112.201% |
| Incannex Healthcare Limited | -30.04 Million USD | 66.541% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 104.006% |
| Alimera Sciences, Inc. | -1.47 Million USD | -583.302% |
| Silver Spike Investment Corp. | 7.34 Million USD | 236.938% |
| Assertio Holdings, Inc. | -243.53 Million USD | 95.873% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -70.583% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 26.187% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | 35.543% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 49.869% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 92.708% |
| Hempacco Co., Inc. | -8.81 Million USD | -14.061% |
| Talphera, Inc. | -16.88 Million USD | 40.486% |
| Alvotech | -354.86 Million USD | 97.168% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 118.804% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 102.757% |
| Currenc Group, Inc. | -6.64 Million USD | -51.244% |
| Kamada Ltd. | 10.06 Million USD | 199.875% |
| Indivior PLC | -4 Million USD | -151.284% |
| Evoke Pharma, Inc. | -7.43 Million USD | -35.265% |
| Flora Growth Corp. | -50.35 Million USD | 80.039% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 49.869% |
| Evolus, Inc. | -49.23 Million USD | 79.584% |
| HUTCHMED (China) Limited | 18.37 Million USD | 154.701% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 105.103% |